AF
RLYB icon

Allworth Financial’s Rallybio RLYB Stock Holding History

Allworth Financial’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54 Hold
6
– – ﹤0.01% 5061
2025
Q4 		$35 Hold
6
– – ﹤0.01% 4879
2025
Q3 		$25 Hold
6
– – ﹤0.01% 4807
2025
Q2 		$17 Buy
+6
New +$16 ﹤0.01% 4528

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Allworth Financial's RLYB Position: Q1 2026 in Review

Allworth Financial held its Rallybio (RLYB) position steady in Q1 2026 at 6 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #5061.

Allworth Financial first reported a position in RLYB in Q2 2025 and has held it in 4 quarters since. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Allworth Financial held 6 shares of Rallybio worth $54 as of Q1 2026.
  • Allworth Financial left its Rallybio share count unchanged in Q1 2026.
  • Rallybio made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5061 holding.
  • Allworth Financial first reported a position in Rallybio in Q2 2025 and has held it in 4 quarters since.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.